Síntomas depresivos como factor de riesgo para polifarmacia en pacientes mayores de 60 años

Granados-Ponce, José Antonio; Peralta-Pedrero, María Luisa; Munguía-Miranda, Catarina; López-Carmona, Juan Manuel; Avila-Leyva, Armando; Rodríguez-Moctezuma, Raymundo.
Gac. méd. Méx ; 143(4): 285-289, jul.-ago. 2007. tab
Artículo en Español | LILACS | ID: lil-568663

Documentos relacionados

  1. Treatment-Resistant Depression in Argentina: results from a longitudinal analysis of the TRAL Study
  2. Do interventions principally targeting excessive alcohol use in young people improve depression symptoms?: a systematic review and meta-analysis.
  3. A systematic review and evaluation of post-stroke depression clinical practice guidelines.
  4. The temporal experience in depression: from slowing down and delayed help seeking to the emergency setting and length of treatment.
  5. A sound mind in a sound body: a novel concept unravelling heterogeneity of depression.
  6. [Efficacy of internet-based interventions for depression available in Germany-A systematic review and meta-analysis].
  7. Functional AGXT2 SNP rs180749 variant and depressive symptoms: Baseline data from the Aidai Cohort Study in Japan.
  8. Pragmatic Clinical Trial of Population Health, Portal-Based Depression Screening: the PORTAL-Depression Study.
  9. The American College of Physicians Living Guideline on Depression: A Step Forward, but Gaps Remain.
  10. [Depressive symptoms as a risk factor for polypharmacy in patients over 60 years of age].